Novavax, Inc. (NVAX) CEO John Jacobs Presents at JPMorgan 42nd Annual Healthcare Conference TranscriptSeeking Alpha • 01/09/24
3 Turnaround Stocks With 151% to 600% Upside in 2024, According to Select Wall Street AnalystsThe Motley Fool • 01/09/24
Novavax's Updated COVID-19 Vaccine Receives Emergency Use Authorization in TaiwanPRNewsWire • 12/18/23
Covid vaccine rates in the U.S. are slumping — and it will be a challenge to boost themCNBC • 11/30/23
Novavax's (NVAX) Updated COVID Jab Gets WHO Nod for Emergency UseZacks Investment Research • 11/29/23
Novavax's stock pops after WHO grants its COVID-19 vaccine emergency-use listingMarket Watch • 11/28/23
Novavax's Updated Protein-based COVID-19 Vaccine Now an Option for All 194 Member States of the World Health OrganizationPRNewsWire • 11/28/23
Is Novavax Stock A Sell After New Covid Shot Fails To Bolster Its Outlook?Investors Business Daily • 11/17/23
Novavax Makes Changes to Executive Leadership Team to Enhance Focus on Delivery of Strategic PrioritiesPRNewsWire • 11/17/23
Novavax, Inc. (NVAX) Presents at Jefferies London Healthcare Conference (Transcript)Seeking Alpha • 11/15/23